Literature DB >> 21389893

Confocal microscopy for the histological fluorescence pattern of a recurrent atypical meningioma: case report.

Wesley J Whitson1, Pablo A Valdes, Brent T Harris, Keith D Paulsen, David W Roberts.   

Abstract

BACKGROUND AND IMPORTANCE: Fluorescence-guided resection with 5-aminolevulinic acid (5-ALA), which has shown promising results in the resection of malignant gliomas, has been used for meningioma resection in an attempt to more clearly delineate the tumor margin. However, no article has investigated the fluorescence pattern of meningiomas on a histological level. Understanding the microscopic pattern of fluorescence could help assess the precision and utility of using 5-ALA for these tumors. We present the case of a recurrent atypical meningioma operated on with 5-ALA fluorescence-guided resection for delineation of tumor tissue from surrounding uninvolved dura. CLINICAL
PRESENTATION: A 53-year-old woman presented with recurrent atypical meningioma of the falx. Prior treatment included surgical resection 6 years earlier with subsequent fractionated radiation therapy and radiosurgery for tumor progression. The patient was given 5-ALA 20 mg/kg body weight dissolved in 100 mL water 3 hours before induction of anesthesia. Intraoperative fluorescence was coregistered with preoperative imaging. Neuropathological analysis of the resected falx with confocal microscopy enabled correlation of fluorescence with the extent of tumor on a histological level.
CONCLUSION: Fluorescence guidance allowed clear intraoperative delineation of tumor tissue from adjacent, uninvolved dura. On a microscopic level, there was a very close correlation of fluorescence with tumor, but some tumor cells did not fluoresce.
Copyright © 2011 by the Congress of Neurological Surgeons

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389893      PMCID: PMC4512294          DOI: 10.1227/NEU.0b013e318217163c

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

1.  Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas.

Authors:  Daniel Coluccia; Javier Fandino; Masayuki Fujioka; Susanne Cordovi; Carl Muroi; Hans Landolt
Journal:  Acta Neurochir (Wien)       Date:  2010-06-10       Impact factor: 2.216

2.  Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resection.

Authors:  Pablo A Valdés; Xiaoyao Fan; Songbai Ji; Brent T Harris; Keith D Paulsen; David W Roberts
Journal:  Stereotact Funct Neurosurg       Date:  2009-11-12       Impact factor: 1.875

3.  Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.

Authors:  David W Roberts; Pablo A Valdés; Brent T Harris; Kathryn M Fontaine; Alexander Hartov; Xiaoyao Fan; Songbai Ji; S Scott Lollis; Brian W Pogue; Frederic Leblond; Tor D Tosteson; Brian C Wilson; Keith D Paulsen
Journal:  J Neurosurg       Date:  2010-04-09       Impact factor: 5.115

4.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

5.  Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas.

Authors:  Ryutaro Ishihara; Yoichi Katayama; Takao Watanabe; Atsuo Yoshino; Takao Fukushima; Kaoru Sakatani
Journal:  Neurol Med Chir (Tokyo)       Date:  2007-02       Impact factor: 1.742

6.  Preoperative identification of meningiomas that are highly likely to recur.

Authors:  S Nakasu; Y Nakasu; M Nakajima; M Matsuda; J Handa
Journal:  J Neurosurg       Date:  1999-03       Impact factor: 5.115

7.  Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.

Authors:  Uwe Pichlmeier; Andrea Bink; Gabriele Schackert; Walter Stummer
Journal:  Neuro Oncol       Date:  2008-07-30       Impact factor: 12.300

8.  Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study.

Authors:  Satoshi Utsuki; Norio Miyoshi; Hidehiro Oka; Yoshiteru Miyajima; Satoru Shimizu; Sachio Suzuki; Kiyotaka Fujii
Journal:  Brain Tumor Pathol       Date:  2007-11-28       Impact factor: 3.298

9.  Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report.

Authors:  Yoshinaga Kajimoto; Toshihiko Kuroiwa; Shin-Ichi Miyatake; Tsugumichi Ichioka; Minoru Miyashita; Hidekazu Tanaka; Motomu Tsuji
Journal:  J Neurosurg       Date:  2007-06       Impact factor: 5.115

10.  Fluorescence-guided resections of malignant gliomas--an overview.

Authors:  W Stummer; H J Reulen; A Novotny; H Stepp; J C Tonn
Journal:  Acta Neurochir Suppl       Date:  2003
View more
  11 in total

1.  Fluorescence depth estimation from wide-field optical imaging data for guiding brain tumor resection: a multi-inclusion phantom study.

Authors:  Dennis Wirth; Kolbein Kolste; Stephen Kanick; David W Roberts; Frédéric Leblond; Keith D Paulsen
Journal:  Biomed Opt Express       Date:  2017-07-14       Impact factor: 3.732

2.  5-Aminolevulinic acid-induced protoporphyrin IX fluorescence in meningioma: qualitative and quantitative measurements in vivo.

Authors:  Pablo A Valdes; Kimon Bekelis; Brent T Harris; Brian C Wilson; Frederic Leblond; Anthony Kim; Nathan E Simmons; Kadir Erkmen; Keith D Paulsen; David W Roberts
Journal:  Neurosurgery       Date:  2014-03       Impact factor: 4.654

3.  Quantitative and qualitative 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in skull base meningiomas.

Authors:  Kimon Bekelis; Pablo A Valdés; Kadir Erkmen; Frederic Leblond; Anthony Kim; Brian C Wilson; Brent T Harris; Keith D Paulsen; David W Roberts
Journal:  Neurosurg Focus       Date:  2011-05       Impact factor: 4.047

Review 4.  5-aminolevulinic acid induced protoporphyrin IX (ALA-PpIX) fluorescence guidance in meningioma surgery.

Authors:  Pablo A Valdes; Matthias Millesi; Georg Widhalm; David W Roberts
Journal:  J Neurooncol       Date:  2019-01-02       Impact factor: 4.130

Review 5.  Fluorescence-guided surgery for brain tumors.

Authors:  Martin Hefti
Journal:  CNS Oncol       Date:  2013-01

6.  Laser biospectroscopy and 5-ALA fluorescence navigation as a helpful tool in the meningioma resection.

Authors:  A A Potapov; S A Goryaynov; V A Okhlopkov; L V Shishkina; V B Loschenov; T A Savelieva; D A Golbin; A P Chumakova; M F Goldberg; M D Varyukhina; A Spallone
Journal:  Neurosurg Rev       Date:  2016-02-18       Impact factor: 3.042

Review 7.  Various shades of red-a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery.

Authors:  Marcel A Kamp; Zarela Krause Molle; Christopher Munoz-Bendix; Marion Rapp; Michael Sabel; Hans-Jakob Steiger; Jan F Cornelius
Journal:  Neurosurg Rev       Date:  2016-05-25       Impact factor: 3.042

Review 8.  The current status of 5-ALA fluorescence-guided resection of intracranial meningiomas-a critical review.

Authors:  Arash Motekallemi; Hanne-Rinck Jeltema; Jan D M Metzemaekers; Gooitzen M van Dam; Lucy M A Crane; Rob J M Groen
Journal:  Neurosurg Rev       Date:  2015-03-05       Impact factor: 3.042

9.  Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas.

Authors:  Walter Stummer; Herbert Stepp; Otmar D Wiestler; Uwe Pichlmeier
Journal:  Neurosurgery       Date:  2017-08-01       Impact factor: 4.654

Review 10.  Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications.

Authors:  Bishnu P Joshi; Thomas D Wang
Journal:  Contrast Media Mol Imaging       Date:  2018-08-27       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.